Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects

PURPOSE: DA-8031 is a novel selective serotonin reuptake inhibitor for the treatment of premature ejaculation. This study investigated the pharmacokinetics, safety and tolerability of multiple oral doses of DA-8031. In addition, a genetic analysis was explored to evaluate the effect of genetic polym...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Sejung, Lee, Dae Young, Cho, Joo-Youn, Chung, Jae-Yong, Jang, In-Jin, Yu, Kyung-Sang, Lee, SeungHwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179755/
https://www.ncbi.nlm.nih.gov/pubmed/34103898
http://dx.doi.org/10.2147/DDDT.S309763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179755/
https://www.ncbi.nlm.nih.gov/pubmed/34103898
http://dx.doi.org/10.2147/DDDT.S309763

Ejemplares similares